U.S. Markets close in 48 mins

Verastem, Inc. (VSTM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.1950-0.0250 (-1.13%)
As of 3:11PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.2200
Open2.2400
Bid2.1900 x 1800
Ask2.2000 x 2200
Day's Range2.1850 - 2.3050
52 Week Range1.0800 - 4.6700
Volume1,422,935
Avg. Volume3,439,841
Market Cap372.654M
Beta (5Y Monthly)1.08
PE Ratio (TTM)N/A
EPS (TTM)-0.6670
Earnings DateNov 09, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Verastem Oncology to Participate in the H.C. Wainwright Global Life Sciences Conference

    Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that the Company will participate in the virtual H.C. Wainwright Global Life Sciences Conference. The fireside chat will be made available for on-demand listening beginning Tuesday, March 9, 2021 at 7:00 a.m. EST.

  • Investors Who Bought Verastem (NASDAQ:VSTM) Shares Five Years Ago Are Now Up 84%
    Simply Wall St.

    Investors Who Bought Verastem (NASDAQ:VSTM) Shares Five Years Ago Are Now Up 84%

    When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...

  • Business Wire

    Frank Neumann, M.D., Ph.D., to Depart Verastem Oncology

    Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the departure of the Company’s Chief Medical Officer, Frank Neumann, M.D., Ph.D., effective immediately. Dr. Neumann has left to accept a position at another Company.